When was Hera Biotech founded?

Hera Biotech was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is Hera Biotech located?

Hera Biotech is headquartered in San Antonio, United States.

How many employees does Hera Biotech have?

As of Mar 31, 2026, the latest employee count at Hera Biotech is 10.

Is Hera Biotech a funded company?

Hera Biotech is a funded company, having raised a total of $3.21M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 11, 2020.

When was the latest funding round of Hera Biotech?

Hera Biotech's latest funding was a $***** Seed round on Sep 10, 2025, with participation from 0 investor.

Where does Hera Biotech rank among its competitors?

Hera Biotech ranks 1st amongst 38 active competitors, of which 10 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Femasys, which secured $8.02M in Nov, 2025.

Who are the top competitors of Hera Biotech?

Hera Biotech's top competitors include Femasys, DotLab and Aindra. Among them, Femasys secured the most recent funding round in November, 2025.

Hera Biotech - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of diagnostic test kit for endometriosis. The company has developed MetriDx a novel, non-surgical method for the early diagnosis and staging of endometriosis. The endometrium is collected using a uterine brush biopsy during an in-office procedure, thereby eliminating the need for surgery.

Key Metrics

Founded Year

2020

Location

San Antonio, United States

Stage

Seed

Total Funding

$3.21M in 5 rounds

Latest Funding Round

Seed, Sep 10, 2025, $*****

Investors

Birmingham Angels & 7 more

Ranked

1^st among 38 active competitors

Employee Count

10 as on Mar 31, 2026

Similar Companies

Femasys & 45 more

View Hera Biotech's full profile

Hera Biotech has raised a total funding of $3.21M over 5 rounds. Its first funding round was on Sep 11, 2020. Hera Biotech has 8 institutional investors.

Here is the list of recent funding rounds of Hera Biotech:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 10, 2025	8812767	Seed	4588200	8199376	1335158	2702283
Apr 11, 2025	8352838	Seed	8285678	6497854	1006789	7962885
May 31, 2023	5270462	Seed	2213663	5070463	7304706	6612235

Access funding benchmarks and valuations. Sign up today!

View details of Hera Biotech's funding rounds and investors

The founders of Hera Biotech are Paul Castella, Bruce Nicholson, Nameer Kirma and Paul Castella.

Here are the details of Hera Biotech's key team members:

Paul Castella: Co-Founder of Hera Biotech.
Bruce Nicholson: Co-Founder of Hera Biotech.
Nameer Kirma: Co-Founder of Hera Biotech.
Paul Castella: Co-Founder & Executive Chairman of Hera Biotech.

View details of Hera Biotech's Founder profiles and Board Members

Hera Biotech's employee count trend

Hera Biotech has 10 employees as of Mar 26. Here is Hera Biotech's employee count trend over the years:

Uncover Hera Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Hera Biotech include Femasys, DotLab and Aindra. Here is the list of Top 10 competitors of Hera Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Hera Biotech 2020, San Antonio (United States), Seed	Developer of diagnostic test kit for endometriosis	$3.21M	Monday Capital, Althea Group & 6 others	60/100
2nd	Femasys 2004, Atlanta (United States), Public	Developer of medical device solutions for womens healthcare	$69.2M	Legacy Capital Advisors, LLC, Salem Partners ... & 2 others	56/100
3rd	DotLab 2016, Branford (United States), Series A	Provider of a molecular diagnostic testing tool for endometriosis in women	$10M	CooperSurgical, Luxor Capital Group & 6 others	53/100
4th	Aindra 2012, Bengaluru (India), Seed	Provider of AI-powered cervical cancer detection system	$304K	Villgro, IKP Knowledge Park & 15 others	53/100
5th	MTM Laboratories 1999, Tucson (United States), Acquired	In vitro diagnostics with a focus on early detection and diagnosis of cervical cancer	$76.1M	National Technology Enterprises Company, HBM Partners ... & 8 others	43/100
6th	OncoHealth 2009, Mountain View (United States), Series A	Protein-based diagnostics for HPV	$1.85M	Wilmington Investor Network, TSVC & 8 others	34/100
7th	Endodiag 2011, Paris (France), Series A	Developer of endometriosis diagnostic solutions	$5.54M	Credit Mutuel Equity, BNP Paribas Developpement ... & 6 others	33/100
8th	EndoGene.Bio 2022, Paris (France), Seed	Developer of non-invasive endometriosis diagnostic tests	-	Entrepreneur First, Loop Ventures	32/100
9th	Self-screen 2008, Amsterdam (Netherlands), Funding Raised	Provider of self-screening solutions for cervical cancer	-	EIC Fund, Europa	32/100
10th	CiceroDx 2015, Huntington Beach (United States), Funding Raised	Provider of molecular diagnostics for women's health	-	NIH, HHS	30/100